DN

Deqiang Niu

BS Bristol-Myers Squibb: 9 patents #5 of 525Top 1%
EP Enanta Pharmaceuticals: 1 patents #5 of 21Top 25%
SA Sanofi: 1 patents #38 of 215Top 20%
📍 Lexington, MA: #7 of 421 inventorsTop 2%
🗺 Massachusetts: #106 of 12,163 inventorsTop 1%
Overall (2016): #7,059 of 481,213Top 2%
10
Patents 2016

Issued Patents 2016

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
9526769 Macrocylic oximyl hepatitis C protease inhibitors Ying Sun, Guoyou Xu, Yat Sun Or, Zhe Wang 2016-12-27
9504686 ERK inhibitors and uses thereof Nadia Haq, Russell C. Petter, Lixin Qiao, Juswinder Singh, Zhendong Zhu 2016-11-29
9458175 MK2 inhibitors and uses thereof Matthew D. Alexander, Claudio Chuaqui, John Malona, Joseph McDonald, Yike Ni +3 more 2016-10-04
9422333 HCV protease inhibitors and uses thereof Russell C. Petter, Lixin Qiao, Juswinder Singh 2016-08-23
9409921 2,4-disubstituted pyrimidines as kinase inhibitors Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni +2 more 2016-08-09
9409887 Mutant-selective EGFR inhibitors and uses thereof Kwangho Lee, Matthew Baevsky 2016-08-09
9375431 2,4-disubstituted pyrimidine compounds useful as kinase inhibtors Kwangho Lee, Russell C. Petter, Matthew Baevsky, Juswinder Singh 2016-06-28
9321786 Heteroaryl compounds and uses thereof Laura Akullian D'Agostino, Robert Tjin Tham Sjin, Joseph McDonald, Zhendong Zhu, Haibo Liu +6 more 2016-04-26
9296737 Substituted 2,4-diaminopyrimidines as kinase inhibitors Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Arthur F. Kluge, Hormoz Mazdiyasni +2 more 2016-03-29
9238629 Heteroaryl compounds and uses thereof Kwangho Lee, Russell C. Petter, Juswinder Singh 2016-01-19